Efeitos da competição de plantas daninhas na cultura do sorgo granífero Sorghum bicolor (L.) Moench.

O trabalho foi realizado com o objetivo de se avaliar o efeitos da competicao de plantas daninhas sobre a cultura do sorgo granifero. O experimento foi conduzido no Centro Nacional de Pesquisa de Milho e Sorgo, em Sete Lagoas - MG, no ano agricola de 1983/84, utilizando-se o hibrido BR 300. A cultura conviveu com a populacao daninha durante duas semanas sem que sua producao fosse reduzida significativamente, mas um aumento no periodo de competicao a partir da quarta semana apos a emergencia da cultura, provocou uma reducao de paniculas por hectare, producao de graos por panicula e producao de graos por hectare

Editorial: Exploring system justification phenomenon among disadvantaged individuals

The question of why (or even when) the disadvantaged might be more or less supportive of existing social arrangements is a matter of debate amongst social and political psychologists (e.g., Passini, 2019; Jost, 2020, see also Rubin et al., 2022). Accordingly, for this Research Topic, we chose a title that was deliberately broad in scope, accommodating several aspects that included: (a) the drivers of system justification; (b) the socio-structural conditions that enhance or dampen system justification, (c) the ideological correlates of system support, and (d) the impact of system justification on wellbeing. Taken together, the contributions comprised in this Research Topic provide a comprehensive analysis of these four issues

Pharmacokinetics and skin concentrations of lincomycin after intravenous and oral administration to cats

The aim of the present study was to describe the plasma pharmacokinetic profile and skin concentrations of lincomycin after intravenous administration of a 15% solution and oral administration of 300 mg tablets at a dosing rate of 15 mg/kg to cats. Susceptibility of staphylococci (n = 31) and streptococci (n = 23) strains isolated from clinical cases was also determined. Lincomycin plasma and skin concentrations were determined by microbiological assay using Kocuria rhizophila ATCC 9341 as test microorganism. Susceptibility was established by the antimicrobial disc diffusion test. Individual lincomycin plasma concentration–time curves were analysed by a non-compartmental approach. After intravenous administration, volume of distribution, body clearance and elimination half-life were 0.97 L/kg ± 0.15 L/kg, 0.17 L/kg ± 0.06 L/h.kg and 4.20 h ± 1.12 h, respectively. After oral administration, peak plasma concentration, time of maximum plasma concentration and bioavailability were 22.52 µg/mL ± 10.97 µg/mL, 0.80 h ± 0.11 h and 81.78% ± 24.05%, respectively. Two hours after lincomycin administration, skin concentrations were 17.26 µg/mL ± 1.32 µg/mL (intravenous) and 16.58 µg/mL ± 0.90 µg/mL (oral). The corresponding skin: plasma ratios were 2.08 ± 0.47 (intravenous) and 1.84 ± 0.97 (oral). The majority of staphylococci and streptococci tested in this study were susceptible to lincosamides (87.09% and 69.56%, respectively). In conclusion, lincomycin administered orally at the assayed dose showed a good pharmacokinetic profile, with a long elimination half-life and effective skin concentration. Therefore, it could be a good first option for treating skin infections in cats

Pharmacokinetics and skin concentrations of lincomycin after intravenous and oral administration to cats

The aim of the present study was to describe the plasma pharmacokinetic profile and skin concentrations of lincomycin after intravenous administration of a 15% solution and oral administration of 300 mg tablets at a dosing rate of 15 mg/kg to cats. Susceptibility of staphylococci (n = 31) and streptococci (n = 23) strains isolated from clinical cases was also determined. Lincomycin plasma and skin concentrations were determined by microbiological assay using Kocuria rhizophila ATCC 9341 as test microorganism. Susceptibility was established by the antimicrobial disc diffusion test. Individual lincomycin plasma concentration-time curves were analysed by a non-compartmental approach. After intravenous administration, volume of distribution, body clearance and elimination half-life were 0.97 L/kg ± 0.15 L/kg, 0.17 L/kg ± 0.06 L/h.kg and 4.20 h ± 1.12 h, respectively. After oral administration, peak plasma concentration, time of maximum plasma concentration and bioavailability were 22.52 μg/mL ± 10.97 μg/mL, 0.80 h ± 0.11 h and 81.78% ± 24.05%, respectively. Two hours after lincomycin administration, skin concentrations were 17.26 μg/mL ± 1.32 μg/mL (intravenous) and 16.58 μg/mL ± 0.90 μg/mL (oral). The corresponding skin: plasma ratios were 2.08 ± 0.47 (intravenous) and 1.84 ± 0.97 (oral). The majority of staphylococci and streptococci tested in this study were susceptible to lincosamides (87.09% and 69.56%, respectively). In conclusion, lincomycin administered orally at the assayed dose showed a good pharmacokinetic profile, with a long elimination half-life and effective skin concentration. Therefore, it could be a good first option for treating skin infections in cats.Facultad de Ciencias Veterinaria